From coordination of care to adherence rate to reimbursement, there’s quite a few reasons your healthcare system should finally enter specialty pharmacy.
Spending in the U.S. on specialty drugs in 2012 was nearly $87 billion; and estimates suggest it could quadruple by 2020, reaching about $400 billion (or 40% of a health plan’s drug spending). The time is now for your health system to get into the rapidly expanding specialty pharmacy industry.
Find out why in this episode of the Specialty Pharmacy Podcast! Click the ‘Play’ button below or subscribe using your favorite podcast service so you can listen on the go and never miss an episode.
About This Episode
This podcast is the first installment of a four-part series which serves as a guide for healthcare systems entering specialty pharmacy.
In this episode, host Suzette DiMascio, CHE, CMCE, CPC, is joined by Marie Anderson, Senior Vice President of Operations and Payor Strategy, Tricia Twaranovica, MS, RN, OCN®, and John Hafl, Senior Vice President of Sales, as they discuss why the majority of hospital systems are jumping on the specialty pharmacy bandwagon. In this podcast, they take a deeper look at academic medical institutions.
Tune in to Discover:
- How to navigate your entry into the specialty pharmacy industry
- The two main obstacles in terms of starting a specialty pharmacy
- Why the patient experience and continuity in their journey can streamline your processes
- The importance of differentiation in specialty pharmacy
Here’s How to Subscribe
- Click here to subscribe via iTunes
- Click here to subscribe via Tunein
- Click here to subscribe via SoundCloud
About The Specialty Pharmacy Podcast
Join host Suzette DiMascio, CHE, CMCE, CPC, President and CEO of CSI Specialty Group, as she answers questions, addresses concerns and discusses the news you need to stay on top of the ever evolving world of specialty pharmacy. Tune in every episode to hear real world examples of the good, the bad and the outrageous from the experts at CSI Specialty Group, and to learn about the limitless growth opportunities available in the specialty pharmacy industry.